Jagiellonian University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Crakow Poland (1364)

Organization Overview

First Clinical Trial
2000
NCT00941551
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Angiology Department, Jagiellonian University Medical College | Coronary Disease Department - Jagiellonian University medical College - Krakow (Poland) | Department of Clinical Nursery, Jagiellonian University | Department of Coronary Disease, Institute of Cardiology, Jagiellonian University Medical College | Department of Internal Medicine and Gerontology - Jagiellonian University Medical College - Krakow (Poland) | Insitute of Cardiology Jagiellonian University Krakow | Institute of Cardiology Jagiellonian University Krakow | Jagellonian University, Krakow, Poland | Jagiellonian University | Jagiellonian University 1 Dept Surgery | Jagiellonian University Colegium Medicum | Jagiellonian University College of Medicine | Jagiellonian University Medical College | Jagiellonian University Medical College Krakow - I Cardiac Department - Krakow (Poland) | KCRI | Polish-American Children's Hospital | Radoslaw Pach, MD, Ph D

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Psoriatic (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Atherosclerosis (Phase 3)

Carcinoma (Phase 1)

Carcinoma, Neuroendocrine (Phase 1)

Communicable Diseases (Phase 4)

Crohn Disease (Phase 4)

Essential Hypertension (Phase 2)

Hypertension (Phase 2)

Infections (Phase 4)

Ischemia (Phase 3)

Osteoarthritis, Knee (Phase 4)

Pain, Postoperative (Phase 4)

Peripheral Arterial Disease (Phase 3)

Peripheral Vascular Diseases (Phase 3)

Spondylitis (Phase 4)

Spondylitis, Ankylosing (Phase 4)

Thyroid Diseases (Phase 1)

Thyroid Neoplasms (Phase 1)

Vascular Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 27
  • # of Trial APIs: 43